Sankalp Malhotra1, Don Hayes2, Daniel J Wozniak3. 1. Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USA; The Ohio State University College of Medicine, Columbus, OH, USA. 2. The Ohio State University College of Medicine, Columbus, OH, USA; Department of Pediatrics, The Ohio State University, Columbus, OH, USA; Section. of Pulmonary Medicine, Nationwide Children's Hospital, Columbus, OH, USA. 3. Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USA; The Ohio State University College of Medicine, Columbus, OH, USA; Department of Microbiology, The Ohio State University, Columbus, OH, USA. Electronic address: Daniel.Wozniak@osumc.edu.
Abstract
BACKGROUND: Pseudomonas aeruginosa is the prominent bacterial pathogen in the cystic fibrosis (CF) lung and contributes to significant morbidity and mortality. Though P. aeruginosa strains initially colonizing the CF lung have a nonmucoid colony morphology, they often mutate into mucoid variants that are associated with clinical deterioration. Both nonmucoid and mucoid P. aeruginosa variants are often co-isolated on microbiological cultures of sputum collected from CF patients. With regional variation in bronchiectasis, tissue damage, inflammation, and microbial colonization, lobar distribution of nonmucoid and mucoid P. aeruginosa variants may impact local microenvironments in the CF lung, but this has not been well-studied. METHODS: We prospectively collected lobe-specific bronchoalveolar lavage (BAL) fluid from a CF patient cohort (n = 14) using a standardized bronchoscopic protocol where collection was performed in 6 lobar regions. The lobar BAL specimens were plated on P. aeruginosa-selective media and proinflammatory cytokines (IL-1, TNF, IL-6 and IL-8) were measured via cytokine array. Correlations between infecting P. aeruginosa variants (nonmucoid, mucoid, or mixed-variant populations), the lobar regions in which these variants were found, and regional proinflammatory cytokine concentrations were measured. RESULTS: P. aeruginosa mucoid and nonmucoid variants were homogenously distributed throughout the CF lung. However, infection with mucoid variants (found within single- or mixed-variant populations) was associated with significantly greater regional inflammation. The upper and lower lobes of the CF lung did not exhibit differences in inflammatory cytokine concentrations. CONCLUSIONS: Mucoid P. aeruginosa infection is a microbial determinant of regional inflammation within the CF lung.
BACKGROUND:Pseudomonas aeruginosa is the prominent bacterial pathogen in the cystic fibrosis (CF) lung and contributes to significant morbidity and mortality. Though P. aeruginosa strains initially colonizing the CF lung have a nonmucoid colony morphology, they often mutate into mucoid variants that are associated with clinical deterioration. Both nonmucoid and mucoid P. aeruginosa variants are often co-isolated on microbiological cultures of sputum collected from CFpatients. With regional variation in bronchiectasis, tissue damage, inflammation, and microbial colonization, lobar distribution of nonmucoid and mucoid P. aeruginosa variants may impact local microenvironments in the CF lung, but this has not been well-studied. METHODS: We prospectively collected lobe-specific bronchoalveolar lavage (BAL) fluid from a CFpatient cohort (n = 14) using a standardized bronchoscopic protocol where collection was performed in 6 lobar regions. The lobar BAL specimens were plated on P. aeruginosa-selective media and proinflammatory cytokines (IL-1, TNF, IL-6 and IL-8) were measured via cytokine array. Correlations between infecting P. aeruginosa variants (nonmucoid, mucoid, or mixed-variant populations), the lobar regions in which these variants were found, and regional proinflammatory cytokine concentrations were measured. RESULTS:P. aeruginosa mucoid and nonmucoid variants were homogenously distributed throughout the CF lung. However, infection with mucoid variants (found within single- or mixed-variant populations) was associated with significantly greater regional inflammation. The upper and lower lobes of the CF lung did not exhibit differences in inflammatory cytokine concentrations. CONCLUSIONS: Mucoid P. aeruginosa infection is a microbial determinant of regional inflammation within the CF lung.
Authors: David S Armstrong; Sarah M Hook; Kris M Jamsen; Gillian M Nixon; Rosemary Carzino; John B Carlin; Colin F Robertson; Keith Grimwood Journal: Pediatr Pulmonol Date: 2005-12
Authors: Amanda F Goddard; Benjamin J Staudinger; Scot E Dowd; Amruta Joshi-Datar; Randall D Wolcott; Moira L Aitken; Corinne L Fligner; Pradeep K Singh Journal: Proc Natl Acad Sci U S A Date: 2012-08-07 Impact factor: 11.205
Authors: Lauren S Mott; Judy Park; Catherine L Gangell; Nicholas H de Klerk; Peter D Sly; Conor P Murray; Stephen M Stick Journal: J Pediatr Date: 2013-01-26 Impact factor: 4.406
Authors: T L Bonfield; J R Panuska; M W Konstan; K A Hilliard; J B Hilliard; H Ghnaim; M Berger Journal: Am J Respir Crit Care Med Date: 1995-12 Impact factor: 21.405
Authors: Shawn T Clark; Julio Diaz Caballero; Mary Cheang; Bryan Coburn; Pauline W Wang; Sylva L Donaldson; Yu Zhang; Mingyao Liu; Shaf Keshavjee; Yvonne C W Yau; Valerie J Waters; D Elizabeth Tullis; David S Guttman; David M Hwang Journal: Sci Rep Date: 2015-06-05 Impact factor: 4.379
Authors: Ashley R Cross; Erika E Csatary; Vishnu Raghuram; Frances L Diggle; Marvin Whiteley; William M Wuest; Joanna B Goldberg Journal: Microbiology (Reading) Date: 2020-09 Impact factor: 2.777
Authors: David A Armstrong; Min Kyung Lee; Haley F Hazlett; John A Dessaint; Diane L Mellinger; Daniel S Aridgides; Gregory M Hendricks; Moemen A K Abdalla; Brock C Christensen; Alix Ashare Journal: Immunohorizons Date: 2020-08-20
Authors: Giovanni Di Bonaventura; Veronica Lupetti; Fabio Verginelli; Sara Giancristofaro; Rosemary Barbieri; Giovanni Gherardi; Arianna Pompilio Journal: Front Microbiol Date: 2022-02-03 Impact factor: 5.640